US FDA sets dates for CFC-inhaler phase-out; last ones in 2013
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration has published a final rule that sets out the dates for the phase-out of the seven remaining metered-dose inhalers used to treat asthma and chronic obstructive pulmonary disease (COPD) that use ozone-depleting chlorofluorocarbon (CFC) propellants.